The prognostic nutritional index predicted mortality more accurately than 2 other composite inflammatory and nutritional markers in patients with IPF.
Boehringer Ingelheim established a presence in idiopathic pulmonary fibrosis years ago with a drug that has become a standard treatment for this serious lung disorder. Now the company has the ...